FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma

BACKGROUND: Segmental genomic copy number alterations, such as loss of 11q or 3p and gain of 17q, are well established markers of poor outcome in neuroblastoma, and have been suggested to comprise tumor suppressor genes or oncogenes, respectively. The gene forkhead box P1 (FOXP1) maps to chromosome...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackermann, Sandra, Kocak, Hayriye, Hero, Barbara, Ehemann, Volker, Kahlert, Yvonne, Oberthuer, André, Roels, Frederik, Theißen, Jessica, Odenthal, Margarete, Berthold, Frank, Fischer, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251948/
https://www.ncbi.nlm.nih.gov/pubmed/25406647
http://dx.doi.org/10.1186/1471-2407-14-840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251948/
https://www.ncbi.nlm.nih.gov/pubmed/25406647
http://dx.doi.org/10.1186/1471-2407-14-840

Ejemplares similares